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Research article 
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Abstract: A sialidase (EC 3.2.1.18; GH 33) from non-pathogenic Trypanosoma rangeli has been 
engineered with the aim of improving its transsialylation activity. Recently, two engineered variants 
containing 15 and 16 amino acid substitutions, respectively, were found to exhibit significantly improved 
transsialylation activity: both had a 14 times higher ratio between transsialylation and hydrolysis products 
compared to the first reported mutant TrSA5mut. In the current work, these two variants, Tr15 and Tr16, 
were characterized in terms of pH optimum, thermal stability, effect of acceptor-to-donor ratio, and 
acceptor specificity for transsialylation using casein glycomacropeptide (CGMP) as sialyl donor and 
lactose or other human milk oligosaccharide core structures as acceptors. Both sialidase variants exhibited 
pH optima around pH 4.8. Thermal stability of each enzyme was comparable to that of previously 
developed T. rangeli sialidase variants and higher than that of the native transsialidase from T. cruzi (TcTS). 
As for other engineered T. rangeli sialidase variants and TcTS, the acceptor specificity was broad: lactose, 
galactooligosaccharides (GOS), xylooligosaccharides (XOS), and human milk oligosaccharide structures 
lacto-N-tetraose (LNT), lacto-N-fucopentaose (LNFP V), and lacto-N-neofucopentaose V (LNnFP V) were 
all sialylated by Tr15 and Tr16. An increase in acceptor-to-donor ratio from 2 to 10 had a positive effect on 
transsialylation. Both enzymes showed high preference for formation α(2,3)-linkages at the non-reducing 
end of lactose in the transsialylation. Tr15 was the most efficient enzyme in terms of transsialylation 
reaction rates and yield of 3’-sialyllactose. Finally, Tr15 was immobilized covalently on glyoxyl-
functionalized silica, leading to a 1.5-fold increase in biocatalytic productivity (mg 3’-sialyllactose per mg 
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enzyme) compared to free enzyme after 6 cycles of reuse. The use of glyoxyl-functionalized silica proved 
to be markedly better for immobilization than silica functionalized with (3-aminopropyl)triethoxysilane 
(APTES) and glutaraldehyde, which resulted in a biocatalytic productivity which was less than half of that 
obtained with free enzyme. 
Keywords: Transsialylation; transsialidase; Trypanosoma rangeli; enzyme immobilization; casein 
glycomacropeptide (CGMP); GH33; human milk oligosaccharides (HMOs); galactooligosaccharides 
(GOS) 
Abbreviations:  
3’SL: 3’-sialyllactose 3SL: 3-sialyllactose 
6’SL: 6’-sialyllactose A:D: acceptor-to-donor ratio 
APTES: (3-aminopropyl)triethoxysilane CGMP: casein glycomacropeptide 
GA: glutaraldehyde GOS: galactooligosaccharides 
GPTMS: (3-glycidyloxypropyl)trimethoxysilane HMO: human milk oligosaccharides 
LNFP V: lacto-N-fucopentaose V LNnFP V: lacto-N-neofucopentaose V 
LNnT: lacto-N-neotetraose LNT: lacto-N-tetraose 
SA: sialic acid SL: sialyllactose 
TcTS: transsialidase from Trypanosoma cruzi THF: tetrahydrofuran 
TrSA: sialidase from Trypanosoma rangeli TrX: TrSA with X amino acid substitutions 
XOS: xylooligosaccharides  
 
 
1. Introduction 
 
Human milk oligosaccharides (HMOs) designate a unique family of bioactive lactose-based 
molecules present in human breast milk (5–15 g/L), which are known to be of major importance for 
infant health and development [1]. However, as they are virtually absent from bovine milk, which is 
used for production of infant formula, production of HMOs receives increasing attention for 
commercial use as well as for functional studies. The concentration of sialylated HMOs is around 1.8 
g/L, corresponding to 19% (w/w) of the HMOs for secretors and as much as 33% (w/w) for non-
secretors [2]. The sialylated HMOs are believed to stimulate the immune system, increase the 
resistance of the breast-fed infant towards pathogens, assist in gut maturation and microbiota 
development, as well as play a role in the brain development of the infant [1,3]. 
One of the few native transsialidases, the transsialidase from the human pathogen Trypanosoma 
cruzi (TcTS) has high transsialidase activity and extremely low hydrolytic activity, and has thus been 
used for efficient enzymatic preparation of sialylated glycans [4-7]. However, for industrial production 
of food-grade HMOs, the fact that TcTS is an important virulence factor in T. cruzi is an indisputable 
obstacle [8]. Consequently, major efforts have been put into engineering the sialidase from non-
pathogenic T. rangeli (TrSA) into an efficient sialidase by substituting amino residues in TrSA by the 
corresponding ones found in TcTS [9,10]. Indeed, TrSA has 70% sequence identity to TcTS and the 
same overall structure, but no transsialidase activity [11,12]. Despite their similarity, it has become 
evident that it is not a simple task to identify the amino acids required for efficient transsialidase 
activity [9,10,13,14]. Introducing five mutations affecting the binding site and the sialic acid binding 
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pocket in TrSA conferred a weak transsialidase activity in the resulting enzyme, TrSA5mut [9]. Either 
of two additional mutations increased the transsialidase activity to 11% of that of TcTS, but also 
increased kcat/Km of the hydrolysis of the desired product, 3’-sialyllactose (3’SL), 1.8-fold [9]. The 
resulting enzyme, Tr6, has subsequently been characterized in terms of optimal reaction conditions 
and thermal stability, used for gram scale production of 3’SL, immobilized, and recycled [15,16]. 
Additional substitution of a seven amino acid loop located near the acceptor binding site reduced the 
hydrolytic activity 4-fold without affecting the transsialidase activity. The mutation, which was based 
on the corresponding loop found in TcTS, introduced a net charge of +3 which was hypothesized to 
cause partial reversal of the water network in the active site, thus impairing the nucleophilicity of the 
water [10]. The resulting engineered sialidase, Tr13, was characterized in terms of optimal reaction 
conditions and thermal stability, used for gram scale production of sialylated galactooligosaccharides 
(GOS), and recycled in an enzymatic membrane reactor [10,17]. Finally, a redesign of TrSA5mut by 
introducing five additional mutations identified by free energy computations was suggested, but not 
validated experimentally [14].  
Recently, the many studies on how to confer transsialidase activity on TrSA were integrated into 
a systematic study including seven expressed mutants, which were investigated for transsialidase and 
sialidase activity using casein glycomacropeptide (CGMP) as donor and lactose as acceptor [18]. This 
led to identification of two novel mutants with improved transsialidase activity and reduced hydrolase 
activity, having 15 and 16 substitutions in the polypeptide backbone, respectively. The mutants were 
named TrSA15mut (Tr15) and TrSA16mut (Tr16) [18]. Tr16 is an integration of Tr13 [10] and the three 
“energetic mutations” T39A, F59N, and D285G, that based on energy decomposition analysis were 
predicted by theoretical modeling to lower the stability of the covalent intermediate (CI) thus 
promoting transsialidase activity [14] (Table 1). Tr15 is identical to Tr16 except for the lack of the 
“structural mutation” I37L, which was hypothesized to increase the participation of the nucleophile at 
the transition state by improving the mobility of the nucleophile [14] (Table 1). The I37L mutation 
improved the formation of transsialylation products, but it also reduced the overall activity 
significantly [18].  
 
Table 1. Mutations introduced in the sialidase from Trypanosoma rangeli (TrSA) to create the 
engineered sialidases used in the current study. In all cases, the residues were mutated to the 
corresponding residue in the transsialidase from Trypanosoma cruzi (TcTS), yielding Tr6 [9], Tr13 [10], 
Tr15 and Tr16 [18], where the number indicates the number of mutations. Amino acid residue 
numbering is based on TrSA. 
Mutation groups Mutations Tr6 Tr13 Tr15 Tr16 
TrSA5mut [9]  M96V, A98P, S120Y, G249Y, Q284P X X X X 
Structural [9,14] I37L X X  X 
Energetic [14] T39A, F59N, D285G   X X 
Loop [10] I197V, A198T, D199N, M200K, G201K, G202K, R203Q  X X X 
 
As part of the current work, the amino acid substitutions introduced in TrSA to create Tr16 were 
visualized in a homology model created using the crystal structure of TrSA (PDB: 1MS9) as a template 
(Figure 1). The trisaccharide 3’SL, which can be a product of transsialylation activity as well as a 
substrate for the sialidase activity, was positioned in the active site by aligning the homology model to 
a crystal structure of TcTS having 3’SL as a ligand (PDB: 1S0I).  
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Figure 1. Homology model of Tr16 (grey; modelled with HHPred and MODELLER using 
1MS9 as template) illustrating the position of the introduced amino acid substitutions (Table 1) 
around the active site, where 3’SL is bound (black lines; from 1S0I). Amino acid substitutions: 
TrSA5mut (purple), loop (salmon), structural (yellow), energetic (pink). Catalytic residues (D60, 
E231, Y343; orange) and other strongly interacting residues not substituted (R36, D97, R246, 
W313, R315; light blue; [49]) are also shown.  
 
When using a glycosidase to catalyze transglycosylation, the reaction is a kinetically controlled 
synthesis [19]. The synthetic reaction (transglycosylation) takes place in competition with hydrolysis 
of both substrate and product, named primary and secondary hydrolysis, respectively (Figure 2). The 
ratio between the transglycosylation rate (rT) and the hydrolysis rate (rH) describes how efficiently the 
glycosyl-enzyme intermediate gives the desired transglycosylation products (Figure 2). Thus, in order 
to maximize transglycosylation yields the ratio rT/rH must be maximized, and [19-21]: 
 
	 ்ݎ
ݎு 	 ൌ 	 ܵ	 ൉ 	
ܽ௚௟௬௖௢௦௬௟	 ௔௖௖௘௣௧௢௥
ܽ௪ ൌ ܵ௖ ൉
ሾ݈݃ݕܿ݋ݏݕ݈ ܽܿܿ݁݌ݐ݋ݎሿ
ሾݓܽݐ݁ݎሿ  Equation 1 
 
In essence, the transglycosylation yield is influenced by the activities (or concentrations) of the 
competing nucleophiles as well as by the selectivity factor S (or Sc), which is dependent on the intrinsic 
properties of the enzyme and also on the choice of donor, acceptor and reaction conditions. It follows 
from the set of reactions (Figure 2), that the maximum yield will be transient unless the secondary 
hydrolysis is negligible [19-21].  
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Figure 2. Reactions catalyzed by the T. rangeli sialidase variants (TrX) when using casein 
glycomacropeptide (CGMP) as sialyl donor and lactose as acceptor. The sialidases (GH 33) 
follow a retaining double displacement mechanism [57], where the nucleophilic attack on the 
sialyl-enzyme intermediate will either lead to transglycosylation or (primary) hydrolysis. The 
ratio between the transglycosylation rate (rT) and the hydrolysis rate (rH) is indicative of the 
transglycosylation performance, and is determined by the properties of the enzyme, donor and 
acceptor substrates, as well as by the reaction conditions [16,19,20]. The regioselectivity of the 
T. rangeli sialidase variants favors formation of 3’-sialyllactose (3’SL), but some 3-sialyllactose 
(3SL) and, in some cases, trace amounts of 6’-sialyllactose (6’SL) are also formed (Figure 4). 
3’SL and 3SL are also substrates for TrX and may thus undergo (secondary) hydrolysis, resulting 
in a transient maximum yield—a characteristic of kinetically controlled synthesis [19,20]. 6’SL 
was not a substrate for Tr6 and Tr13 [10]. 3’SL and 6’SL are known HMOs, while 3SL is not. 
Lactose is used as an example of an acceptor here; other possible acceptors are given in Table 4.  
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The aim of this paper is to characterize the two superior engineered T. rangeli sialidases, Tr15 
and Tr16, and notably to compare different enzyme immobilization strategies in order to accomplish 
efficient, enzymatic transsialylation. It was hypothesized that Tr15 and Tr16 would be more efficient 
than their predecessors TrSA6mut (Tr6) and TrSA13mut (Tr13) in transsialylation at low acceptor-to-
donor ratios—a prerequisite for working with transsialylation of expensive acceptor substrates such as 
lacto-N-tetraoses, which is often neglected because the sialidase-catalyzed transsialylation is enhanced 
by high acceptor-to-donor ratios [22]. In this context, acceptor specificity of Tr15 and Tr16 was also 
assessed.  
The biocatalytic productivity of an enzyme, i.e. amount of product per amount of enzyme, can be 
improved by enzyme immobilization as it facilitates recycling of the enzyme. Furthermore, 
immobilization may increase enzyme stability, activity, specificity, and/or selectivity and may also 
reduce inhibition effects by the medium or products [23,24]. The use of porous supports can generate 
favourable microenvironments leading to an improvement of enzyme performance. Porous supports 
may promote desirable diffusional limitations such as substrate/product concentration gradients or pH 
gradients, have protective effects on the confined enzyme, or block certain areas which in turn prevents 
enzyme inhibition [24]. Covalent immobilization is the most widely applied method in industrial 
applications due to several advantages including improved operational stability, robustness and 
reusability. Glutaraldehyde is a popular and versatile reagent in protein immobilization because 
although it normally reacts with primary amino groups in the protein, it can also react with thiol, phenol 
and imidazole groups. The mechanisms behind glutaraldehyde-mediated immobilization are not fully 
understood, but it is clear that the mechanisms differ depending on the pH [25]. At neutral and acidic 
conditions as employed in the current work, the cyclic hemiacetal forms of both monomeric and 
polymeric glutaraldehyde would react by nucleophilic substitution amino groups on the protein surface 
of the enzyme with the hydroxyl group of glutaraldehyde [25]. At neutral or acidic pH, the most 
reactive amino group is the terminal one with a pKa value of 7.7 compared to the pKa value of 10.5 of 
the ε-amino groups of Lys residues and it is thus likely that the first covalent bond is formed with the 
N-terminal [25,26]. However, when the enzyme is thus brought into proximity with glutaraldehyde 
moieties on the support, it is likely that further covalent enzyme-support bonds will be formed if other 
nucleophiles on the enzyme are present on the side facing the support. Alternatively, the enzyme can 
be adsorbed to the support through hydrophobic interaction once the unipoint covalent linkage to 
glutaraldehyde is formed [25]. Enzyme immobilization on glyoxyl-functionalized supports establishes 
multipoint covalent bonds to several reactive primary amines, mainly ε-amino groups of surface Lys 
residues. Immobilization must take place at alkaline conditions (pH 10) and requires a highly activated 
support. This kind of immobilization occurs through more than one simultaneous enzyme-support 
interaction. In fact, the density of reactive groups is a driving force, and as a consequence immobilization 
takes place in the area(s) where the enzyme has the highest density of Lys residues [27]. A final step is 
the reduction with sodium borohydride of Schiff’s bases between amino and glyoxyl groups into stable 
secondary amino bonds and of all remaining glyoxyl (aldehyde) groups into inert, hydrophilic 
hydroxyl groups [27-29].  Glyoxyl-functionalized agarose or silica supports permit a fair enzyme 
stabilization and reuse without leakage of the enzyme into the medium [23,27]. Agarose support has 
been widely used with successful results [30,31]. Alternatively, silica supports with porous structures 
offer several advantages as high surface area, non-toxicity, microbe resistance, ease of handling, and 
robustness towards high flow rates in continuous reactors and have been used successfully for glyoxyl 
immobilization of β-galactosidases [32-34].  
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Recently, the commercial crude extract Pectinex Ultra SP-L, which includes β-galactosidase from 
Aspergillus aculeatus, was immobilized on a glyoxyl-functionalized porous silica support with a wide 
pore size [35]. The immobilized biocatalyst demonstrated an improved yield of 
galactooligosaccharides (GOS) compared to the use of free enzyme. Furthermore, the ratio between 
transgalactosylation and hydrolysis was improved by immobilization. This was probably due to a 
combination of proper hydrophobic/hydrophilic surface balance and a confinement effect of substrates 
and products inside the pores of the support [35]. As β-galactosidases and sialidases share a similar 
reaction mechanism [22] (Figure 2), it was hypothesized that transsialylation catalyzed by the 
engineered T. rangeli sialidases would benefit from immobilization on porous silica support grafted 
with glyoxyl [35]. For comparison, the sialidases were immobilized in the same porous silica support 
grafted with (3-aminopropyl)triethoxysilane (APTES) and glutaraldehyde (GA). The APTES-GA 
method is the most popular route to covalent immobilization of biomolecules including enzymes on 
silica supports [32,36-38], and therefore serves as a good comparison to the glyoxyl method. 
Additionally, two methods of recycling, centrifugation and fed-batch, were evaluated for all the 
biocatalysts synthesized. It was hypothesized that enzyme immobilization would improve the 
biocatalytic productivity in the transsialylation reaction and that its covalent nature would result in less 
leakage of the enzyme from the support than observed previously for Tr6 [15]. In that study, the most 
successful method, immobilization on Cu2+-iminodiacetic acid-functionalized magnetic nanoparticles 
via the His-tag, resulted in a reduction in transsialylation activity to as little as 14% in just four 1-hour 
reaction cycles, mainly due to enzyme leakage [15].  
 
2. Materials and Methods 
 
2.1. Chemicals 
 
3’-sialyllactose (3’SL) and 6’-sialyllactose (6’SL) were purchased from Carbosynth Ltd 
(Compton, UK). Casein glycomacropeptide (CGMP), in the form of the commercial product 
Lacprodan CGMP-20, and galactooligosaccharides (GOS) 570-P (product of King-Prebiotics, Yunfu, 
China) were kindly provided by Arla Foods Ingredients Group (Viby, Denmark). GOS Cup Oligo P 
(Nissin Sugar Co., Tokyo, Japan) were purchased from Giulio Gross (Trezzano sul Naviglio, Italy). 
Xylooligosaccharides (XOS) from Longlive Biotechnology (Shandong, China) were a gift from Dr. 
Arthur Ouwehand (DuPont Nutrition & Health, Kantvik, Finland). Silica support Sipernat 50S was 
kindly donated by Evonik Resource Efficiency GmbH (Essen, Germany). Glutaraldehyde was kindly 
provided by Novozymes A/S (Bagsværd, Denmark). Glycerol was purchased from VWR (Leuven, 
Belgium) and tetrahydrofuran (THF) from Fisher Scientific (Loughborough, UK). Lacto-N-tetraose 
(LNT), lacto-N-neotetraose (LNnT), lacto-N-fucopentaose V (LNFP V), and lacto-N-neofucopentaose 
V (LNnFP V) were purchased from Elicityl Oligotech (Crolles, France). All other chemicals were 
purchased from Sigma-Aldrich (Steinheim, Germany).  
 
2.2. Enzyme production and purification 
 
Codon-optimized gene constructs of Tr6 and Tr13 for expression in Pichia pastoris were 
synthesized by DNA 2.0 (Menlo Park, CA, USA), and further mutations were introduced using the 
QuikChange II Site-Directed Mutagenesis Kit (Agilent, CA, USA) and mutagenic primers [18]. For 
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high cell density fermentation of His6-tagged Tr6, Tr13, Tr15, and Tr16, P. pastoris X-33 strains each 
harboring pPICZαC with the particular mutated enzyme gene was fermented in a 5 L Sartorius Biostat 
Aplus fermentor as described previously [16]. Purification of the His6-tagged enzymes was performed 
by Ni2+ affinity column chromatography as described previously [15]. Protein concentrations were 
determined by the BCA protein assay kit (Thermo Scientific, Rockford, USA) with bovine serum 
albumin as external standard.  
 
2.3. Thermal stability and pH optimum  
 
Thermal stability of Tr15 and Tr16 was determined by incubation of the enzymes at 30, 40, 45, 
50, and 55 °C for relevant times up to 2 hours, followed by determination of residual transsialidase 
activity. The pH optima of Tr15 and Tr16 were determined at 30 °C in 160 mM phosphate-citrate 
buffer solutions over a resulting pH range from 3.9 to 7.7, where the exact pH was measured in each 
sample; the uneven numbers were caused by the large buffering effect of CGMP, emphasizing the 
need for measuring the exact pH in the sample. In both cases, transsialidase activity was assessed using 
34 g/L CGMP (corresponding to 8 mM bound sialic acid) as donor substrate, 80 mM β-lactose as 
acceptor, and an enzyme concentration of 6 mg/L. For the thermal stability tests, the reaction time was 
20 min, whereas it was 10 min for Tr15 and 30 min for Tr16 in the pH optimum studies. The reaction 
was terminated by heat enzyme inactivation at 90 °C for 10 min. The samples were filtered on a 5 kDa 
polyethersulfone membrane (Vivaspin 500; Sartorius AG, Göttingen, Germany) to remove CGMP 
before the concentrations of sialyllactose (SL) were determined by HPAEC-PAD (see below).  
 
2.4. Time study at varying acceptor-to-donor ratio 
 
The effect of acceptor-to-donor (A:D) ratio was evaluated for Tr13, Tr15, and Tr16 in a time 
study, where the reaction was monitored for 3 hours. The reactions were run at 30 °C in 160 mM 
phosphate-citrate buffer solution at resulting optimal pH (pH 5.5 for Tr13 [17], and pH 4.8 for Tr15 
and Tr16), using 34 g/L CGMP (corresponding to 8 mM bound sialic acid [17]) as donor substrate, 16 
or 80 mM β-lactose as acceptor (A:D = 2 or A:D = 10, respectively), and an enzyme concentration of 
6 mg/L. Reactions were stopped at relevant time points between 0 min and 3 hours and prepared for 
HPAEC-PAD analysis as above. Since the transglycosylation yield is influenced by product 
hydrolysis, only initial rates of substrate hydrolysis and transglycosylation product formation were 
considered when calculating reaction rates rT and rH.  
 
2.5. Transsialylation of LNT, LNnT, LNFP V, LNnFP V, GOS, and XOS 
 
For transsialylation of alternative acceptors LNT, LNnT, LNFP V, LNnFP V, XOS, and GOS 
with Tr15 and Tr16, the reaction took place for up to 4 hours at 30 °C in 160 mM acetate buffer at pH 
4.8, using 34 g/L CGMP (corresponding to 8 mM bound sialic acid) as donor substrate, 80 mM LNT, 
LNnT, LNFP V, or LNFP V or 27.5 g/L GOS or XOS as acceptor, and an enzyme concentration of 6 
mg/L. Negative controls were performed with heat-inactivated enzyme. The reaction was terminated 
by heat enzyme inactivation at 90 °C for 10 min. For transsialylations of LNT, LNnT, LNFP V, and 
LNnFP V, the samples were filtered on a 5 kDa polyethersulfone membrane (Vivaspin 500; Sartorius 
AG, Göttingen, Germany) to remove CGMP. For all GOS or XOS transsialylations, the heat-
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inactivated reaction mixture was subjected to anion exchange chromatography on a HiTrap Q FF 
column (GE Healthcare, Uppsala, Sweden) as described previously [17] in order to purify the 
sialylated compounds prior to LC-MS analysis to simplify the analyzed mixture.  
 
2.6. Preparation of glyoxyl and APTES-GA silica supports 
 
Sipernat 50S silica support was glyoxyl grafted as described previously [35]: Sipernat 50S silica 
support was dried overnight by vacuuming at 55 °C and 0.2 bar and then grafted with epoxy groups 
suspending 1 g of silica in 50 mL of dry toluene, 1 mL of (3-glycidyloxypropyl)trimethoxysilane 
(GPTMS) and 150 µL of triethylamine. After 4 hours of stirring and reflux under nitrogen, the solid 
was filtered off and washed thoroughly with THF. Finally, the epoxy-modified silica was dried during 
12 hours at 55 °C. Afterwards, the hydrolysis of the epoxy groups was carried out by mixing 1 g of 
solid with 10 mL of 0.1 M H2SO4 for 2 hours at 85 °C. After washing with water/acetone (70:30 v/v) 
and drying, the resulting glyceryl-epoxide silica was subjected to a further oxidation step of the 
glyceryl moieties by reacting with 0.03 M NaIO4 for 2 hours at room temperature. The formation of 
the glyoxyl groups on the silica surface was quantified by back-titration with NaHCO3/KI, measuring 
the difference in absorbance at 405 nm of the supernatant before and after the oxidation process.  
Sipernat 50S silica support was grafted with (3-aminopropyl)triethoxysilane (APTES) and 
glutaraldehyde (GA) as follows: 2 g of silica support was mixed with 2% (v/v) APTES solution for 2 
hours at 70 °C with vigorous stirring [36,37]. After washing with MilliQ water, the support was 
incubated in 2.5% (v/v) glutaraldehyde solution (pH 7) for 1 hour at room temperature with moderate 
stirring. After washing with MilliQ water, the support was dried overnight at 35 °C and vacuum (0.2 
bar).  
 
2.7. Enzyme immobilization on glyoxyl and APTES-GA silica supports 
 
Ultrafiltered, cell-free extracts of Tr6 and Tr15 were used for immobilization without further 
purification. The immobilization on the glyoxyl silica support was carried out by suspending 0.5 g of 
glyoxyl silica support in 5 mL of enzyme preparation diluted in 100 mM potassium bicarbonate (pH 
10.5), corresponding to approximate 35 mg enzyme being offered per g support. The suspension was 
maintained for 2 hours at 4 °C under vigorous stirring. In order to avoid enzyme inactivation at high 
pH, 100 mM galactose and 25% (v/v) glycerol was added as optimized previously [31]. Subsequently, 
Schiff’s bases of the support were reduced in 1 g/L sodium borohydride in a 160 mM phosphate-citrate 
buffer at optimum pH for the enzymes (pH 4.8 for Tr15, pH 5.5 for Tr6 [16]) [31,33,35]. Finally, 
biocatalyst was washed with 160 mM phosphate-citrate buffer at their optimum pH. The obtained 
biocatalysts were named glyoxyl-TrX. 
Immobilization of APTES-GA silica support was carried out following the same process as 
above, but rather than high pH, the optimum pH (pH 4.8 for Tr15, pH 5.5 for Tr6) was used for the 
immobilization, which took place at 4 °C overnight; longer time was employed to compensate for the 
pH conditions being more favourable for enzyme stability than for immobilization. Protein 
concentration in the immobilization mixture before and after immobilization was determined by the 
BCA protein assay kit (Thermo Scientific, Rockford, USA) to estimate the immobilization efficiency. 
The obtained biocatalysts were named APTES-GA-TrX. 
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2.8. Recycling study for immobilized enzyme on glyoxyl and APTES-GA silica supports 
 
Transsialylation activity of immobilized Tr6 and Tr15 was determined by suspending 0.5 g of 
glyoxyl-TrX or APTES-GA-TrX in a 50 mL reaction mixture containing 34 g/L CGMP (corresponding 
to 8 mM bound sialic acid) and 80 mM β-lactose in 160 mM phosphate-citrate buffer (pH 4.8 for Tr15, 
pH 5.5 for Tr6). Reactions were performed in duplicates following either the centrifugation method or 
the fed-batch method for biocatalyst recycling.  
The centrifugation method was accomplished in a 100 mL round-bottom flask with stirring 
permitting suspension of the biocatalyst in a 50 mL reaction volume. After 50 min of reaction, all the 
reaction volume was centrifuged at 8600 g for 5 min at room temperature. The supernatant was kept 
at 90 °C for 10 min to inactivate residual activity and stored for analysis. The biocatalyst was reused 
by suspending it in 50 mL of fresh reaction mixture for the next reaction cycle. The whole process was 
repeated until 6 cycles of biocatalyst recycling were completed.  
The fed-batch method was started in a 100 mL round-bottom flask with stirring permitting 
suspension of the biocatalyst in a 50 mL reaction volume. After 50 min of reaction, a small sample 
was withdrawn and centrifuged at 8600 g for 5 min at room temperature. The supernatant was kept at 
90 °C for 10 min to inactivate residual activity and stored for analysis. The biocatalyst was reused by 
adding another 50 mL of fresh reaction mixture to a round-bottom flask already containing the reaction 
mixture and biocatalyst from the previous cycle. The process was repeated until 6 cycles of biocatalyst 
recycling were completed, adjusting the size of the round-bottom flask in order to maintain the same 
proportion between the reaction volume and the flask throughout.  
In both methods, temperature was kept at 30 °C using a water bath placed over a heating plate 
equipped with a thermocouple sensor probe for temperature control. The inactivated supernatant 
samples were filtered on a 5 kDa polyethersulfone membrane (Vivaspin 500; Sartorius AG, Göttingen, 
Germany) to remove CGMP before the concentrations of SL were determined by HPAEC-PAD. For 
comparison, a reaction with free enzyme in a concentration corresponding to the immobilization 
efficiency (approximate 0.85 mg for 50 mL of reaction mixture) was monitored for 6 hours.  
 
2.9. HPAEC-PAD analysis 
 
Separation and quantification of sialic acid, 3’SL, 6’SL, and 3SL in the standard transsialylation 
activity assays were carried out by high performance anion exchange chromatography with pulsed 
amperometric detection (HPAEC-PAD) using a CarboPacTM PA100 (4 × 250 mm) analytical column 
equipped with a CarboPacTM PA100 (4 × 50 mm) guard column (Dionex Corp., Sunnyvale, CA) on a 
Dionex ICS-3000 system (Dionex Corp., Sunnyvale, CA). The operating conditions and analysis 
procedure have been described previously [17], and resulted in base line separation of the analytes. Sialic 
acid (Sigma-Aldrich, Steinheim, Germany), 3’SL, and 6’SL (Carbosynth Ltd, Compton, UK) were used 
as external standards. For 3SL, where no standard was available, the product formation was estimated as 
3’SL equivalents. 3SL was identified previously [39], and its identity was confirmed by HPAEC-PAD and 
LC-MS analyses of the reaction mixtures as well as of β-galactosidase treated reaction product mixtures.  
 
2.10. LC-MS analysis of transsialylated oligosaccharides 
 
Identification of sialylated HMOs, GOS and XOS was performed by liquid chromatography 
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electrospray ionization mass spectrometry (LC-ESI-MS) on an Amazon SL iontrap (Bruker Daltonics, 
Bremen, Germany) coupled to an UltiMate 3000 UHPLC from Dionex (Sunnyvale, CA, USA). 5 µL 
sample was injected on a porous graphitized carbon column (Hypercarb PGC, 150 mm × 2.1 mm; 3 
µm, Thermo Fisher Scientific, Waltham, MA, USA). The chromatography was performed at 0.3 
mL/min at 70 °C on a two eluent system with eluent A (0.1% formic acid in water) and eluent B 
(acetonitrile). The elution profile was as follows: 0–1 min, 0% B; 1–38 min, linear gradient to 27.5% 
B; 38–41 min, linear gradient to 60% B; 41–75 min, isocratic 60% B; 75–80 min, isocratic 0% B. The 
electrospray was operated in negative mode with UltraScan mode and a scan range from 100-2000 
m/z, smart parameter setting of 500 m/z, capillary voltage at 4.5 kV, end plate off-set 0.5 kV, nebulizer 
pressure at 3.0 bar, dry gas flow at 12.0 L/min, and dry gas temperature at 280 °C. CID fragmentation 
was performed using SmartFrag enhanced amplitude ramping from 80 to 120%, fragmentation time 
20 ms. Identification was performed by interpretation of MS3 spectra in Compass QuantAnalysis 2.2 
(Bruker Daltonics, Bremen, Germany). 
 
2.11. Bioinformatics 
 
The homology model Tr16 was created with HHPred and MODELLER [40], using a crystal structure 
of TrSA (PDB: 1MS9) as template. Graphics were prepared with the PyMOL Molecular Graphics System, 
version 1.8 (Schrödinger, LLC). 1S0I was used for fitting the 3’SL ligand as well as for adjusting the 
rotation of the Y120 side chain in PyMOL. Average diameters of TrSA5mut (PDB: 1WCS) and β-
galactosidase from Aspergillus aculeatus (PDB: 1FOB) were calculated using RasMol 2.7.5 [41].  
 
2.12. Statistics  
 
One-way ANOVA for determination of statistical significance was performed with JMP®, 
version 12.1.0 (SAS Institute Inc., Cary, NC). Statistical significance was established at p < 0.05.  
 
3. Results and Discussion 
 
3.1. Thermal stability 
 
Thermal stability was determined for Tr15 and Tr16 (Table 2). At 30 °C, both enzymes were 
completely stable (kD = 0), whereas their half-lives were more than 13 hours at 40 °C. At 45 °C, half-
lives were around 1.5 hours, decreasing to 23 min for Tr15 and 9 min for Tr16 at 50 °C. At 55 °C, 
inactivation was rapid with half-lives around 3–4 min (Table 2). Comparing to the thermal stability 
data obtained for Tr6 and Tr13 [15,17], there is a tendency that Tr6 was more thermostable than Tr13, 
which was slightly more thermostable than Tr15, which was in turn slightly more stable than Tr16 
(Table 2). This indicates that an increase in number of point mutations in TrSA has an increasingly 
negative effect on the thermal stability of the sialidase. It has been known for decades that point 
mutations influence protein stability differently [42]; possibly, the introduction of three adjacent, 
positively charged amino acids (M200K, G201K, G202K) causes charge repulsion, which is slightly 
harmful to the enzyme’s thermal stability [43,44]. Nevertheless, all the engineered T. rangeli sialidases 
(Tr6, Tr13, Tr15, and Tr16) had a markedly higher thermal stability than TcTS [17], emphasizing the 
potential of the engineered sialidases in practical applications (Table 2).  
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Table 2. Thermal stability of Tr15 and Tr16 compared to previously obtained data on Tr6, Tr13, and 
TcTS. Half-life (t½) given in min ± standard deviation with corresponding thermal inactivation 
constants, kD, given in min−1 in parenthesis. Superscript letters indicate significant difference between 
the enzymes at each temperature (p < 0.05). Empty fields indicate that the enzyme was not tested at 
the given temperature.  
°C Tr6e Tr13f Tr15 Tr16 TcTSf 
30  - (0)a - (0)a - (0)a > 210 (0.003)b 
40  > 7980 (8.7 × 10−5)a > 780 (8.7 × 10−4)a > 780 (8.4 × 10−4)a 14 ± 2 (0.051)b 
45 - (0)a 236 ± 82 (0.003)b 106 ± 20 (0.007)b 84 ± 25 (0.008)b 1.9 ± 0.7 (0.363)c 
50 37 ± 3 (0.019)a 37 ± 2 (0.019)a 23 ± 0.6 (0.030)b 9.2 ± 1.4 (0.076)c 0.6 ± 0.2 (1.089)d 
55  2.8 ± 0.2 (0.251)a 4.3 ± 0.6 (0.161)a 3.0 ± 1.1 (0.229)a  
60 5.2 ± 0.5 (0.134)     
65 0.9 ± 0.2 (0.806)     
eData from [15]; fdata from [17].  
 
 
 
Figure 3. pH optima of Tr15 and Tr16. The effect of pH on the transsialylation activity of Tr15 
(triangles; left axis) and Tr16 (circles; right axis) was measured as the concentration of 3’SL 
present after 10 min and 30 min of reaction, respectively. The pH was measured in the sample 
right after the reaction. Standard deviations of triplicate experiments are indicated.  
 
3.2. Optimal pH 
 
The transsialidase activity vs. pH curves appear similar for Tr15 and Tr16, both showing pH 
optima around pH 4.8 (Figure 3). Previously, a pH optimum around pH 5.5 was reported for Tr13 [17]. 
Several examples of amino acid substitutions leading to shift in pH optima have been reported. 
However, while some report a shift toward a more acidic pH optimum upon substituting negatively 
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charged amino acids with uncharged ones [45,46] as is seen here for D285G, the opposite effect has 
also been reported [47,48]. In any case, the introduction of T39A, F59N, and D285G led to a decrease 
in pH optimum from pH 5.5 to pH 4.8 for the engineered sialidases from T. rangeli. T39A is quite far 
from the 3’SL ligand (13 Å), but close to R36, which is part of the arginine triad responsible for sialyl 
carboxylate fixation, and the structural mutation I37L found in Tr16 (Figure 1; [49]). The other two 
energetic mutations are closer to the substrate (5–6 Å), and F59N is adjacent to the general acid/base 
catalyst D60 [49], while D285G is adjacent to the TrSA5mut mutation Q284P (Table 1, Figure 1). Below 
pH 4 there is no detectable activity (Figure 3).  
 
3.3. Reaction rates and effect of acceptor-to-donor ratio  
 
It has previously been shown that Tr13 has a transsialylation activity similar to that Tr6, but a 
significantly lower hydrolytic activity (62% on CGMP, 24% on 3’SL) [10]. In the current study, the 
reaction rates of the newly engineered T. rangeli sialidases Tr15 and Tr16 were compared to those of 
Tr13 (Figure 4). The transsialylation and competing hydrolysis catalyzed by Tr13, Tr15, and Tr16 
were monitored for 3 hours at acceptor-to-donor ratios (A:D) of 2 and 10, using a concentration of 
sialic acid bound in CGMP of 8 mM and lactose concentrations of 16 mM and 80 mM, respectively. 
A high A:D is known to favor transsialylation [10,16,22], whereas a lower A:D is more relevant for 
expensive acceptors such as larger HMO core structures. 
It is evident that increasing A:D from 2 to 10 had a major effect on the ratio between the 
transsialylation rates and the hydrolysis rate (rT/rH) for all three engineered sialidases (Table 3). In all 
cases, significantly lower hydrolysis rates were observed when A:D was increased (Figure 4). The 
transsialylation rates were doubled for Tr13 when A:D was increased from 2 to 10, whereas the 
increase was more moderate for Tr15 and absent for Tr16 (Figure 4). As a consequence, significant 
increases in sialyllactose (SL) yields were observed for Tr13 and Tr15 when A:D was increased from 
2 to 10 (Table 3). As the reaction is a kinetically controlled synthesis, it is expected that a higher 
acceptor concentration (5 times higher at A:D = 10 compared to A:D = 2) would give a higher rT/rH 
(Equation 1). 
 
Table 3. Ratio between reaction rates of transsialylation and hydrolysis (rT/rH = (r3’SL + r6’SL + 
r3SL)/rSA), maximum concentration of SL (sum of 3’SL, 6’SL and 3SL), and regioselectivity for 
3’SL in the transsialylation obtained with Tr13, Tr15, and Tr16 during 3 hours of reaction using 
acceptor-to-donor ratios (A:D) of 2 or 10, i.e. 8 mM bound sialic acid in CGMP and 16 or 80 mM 
lactose, respectively. Superscript letters indicate significant difference (p < 0.05) between SL 
levels.  
 A:D Tr13 Tr15 Tr16 
rT/rH 2 3.8 3.7 2.8 
 10 31 36 58 
Max. SL produced [µM] 2 109 ± 8c 331 ± 85b 46 ± 6c 
 10 299 ± 47b 690 ± 11a 38 ± 3c 
Regioselectivity (% 3’SL in TS) 2 97% 98% 100% 
 10 97% 97% 100% 
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Figure 4. Initial reaction rates for production of sialic acid (SA; hydrolysis), 3’SL, 6’SL, and 
3SL (transsialylation) obtained with Tr13, Tr15, and Tr16 using acceptor:donor ratios (A:D) of 
2 or 10, i.e. 8 mM bound sialic acid in CGMP and 16 or 80 mM lactose, respectively. Standard 
deviations of duplicate experiments are indicated.  
 
The highest rT/rH was obtained with Tr16 at an A:D of 10 (Table 3). However, Tr16 also had the 
lowest reaction rates (Figure 4) and hence the lowest transsialylation yield within the fixed reaction 
time (Table 3). In fact, reaction rates were so low that the large difference in rT/rH observed for Tr16 
between the low and high A:D levels did not manifest itself in the transsialylation yields within the 
limited reaction time (Table 3). Indeed, it was evident from previous results [18] that the structural 
mutation I37L was detrimental to the reaction rate, especially in combination with the loop mutations. 
This trend is emphasized here: Tr15, which is the only enzyme of the three which does not harbor the 
structural mutation I37L (Table 1), exhibits much higher reaction rates (Figure 4) and transsialylation 
yields (Table 3). Indeed, the SL level achieved with Tr15 at an A:D of 2 was as high as the one achieved 
with Tr13 with an A:D of 10 (Table 3). In conclusion, Tr13 has benefitted from losing the structural 
mutation (I37L) and gaining the energetic mutations (T39A, F59N, and D285G). Previous results 
showed that only losing the structural mutation (i.e. TrSA12mut) did not have a positive effect, especially 
not on rT/rH [18]. Similarly, addition of energetic mutations to Tr13 (i.e. Tr16) almost doubled rT/rH at 
an A:D of 10, but the reaction rates were significantly lower. However, at an A:D of 2, Tr16 seemed 
to perform more poorly than Tr13, although this difference was not significant (Table 3).  
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All three engineered sialidases showed high preference for producing 3’SL (Figure 4; Table 3). 
Tr16 produced no other detectable SLs. Tr13 and Tr15 produced small but detectable amounts of 3SL, 
while only Tr15 produced detectable levels of 6’SL (Figure 4). A high regioselectivity towards 
formation of α(2,3)-linkages was expected as this has previously been observed for the TrSA mutants 
as well as for TcTS [22].  
Although neither Tr15 nor Tr16 outperformed their predecessor Tr13 in terms of rT/rH at low 
A:D, it is evident that Tr15 is a much more potent enzyme in terms of transsialylation rates (Figure 4; 
Table 3) at both high and low A:D. While Tr16 is less efficient than both Tr13 and Tr6 in terms of 
transsialylation rates, it is superior when it comes to the rT/rH ratio at high A:D, possibly evidence of 
a higher selectivity factor S (Equation 1). It was previously shown, that when dosed 10 times higher, 
Tr16 performed better than Tr15 at an A:D of 2 [18]. The high rT/rH ratio achieved at an A:D of 10 
makes it possible to achieve high transsialylation yields without the need for tight reaction time control, 
which is otherwise necessary for glycosidases with a low rT/rH, where the transglycosylation has a 
transient maximum [22]. However, in most applications Tr15 appears to be the obvious choice as it is 
a more efficient enzyme. Indeed, it is evident from the results that a high rT/rH ratio is not everything: 
because of a markedly higher transsialylation rate, Tr15 produced much more SL at both low and high 
A:D even though its rT/rH ratios are identical to the ones obtained with Tr13 (Table 3).  
 
3.4. Acceptor specificity of Tr15 and Tr16 
 
The engineered T. rangeli sialidases, Tr6 and Tr13, as well as TcTS have been used for catalyzing 
the formation of a number of sialylated glycans, including GOS and HMO core structures lactose, 
lacto-N-tetraose (LNT), lacto-N-neotetraose (LnNT), lacto-N-fucopentaose I (LNFP I) and lacto-N-
fucopentaose V (LNFP V) [4,6,7,10,16,17]. Indeed, the acceptor specificity seems to be broad for these 
enzymes, and goes beyond terminal β-galactosyl moieties as initially suggested for TcTS [5,10,22,50]. 
It was hypothesized that an equally broad acceptor specificity would be observed for Tr15 and Tr16.  
The ability of Tr15 and Tr16 to catalyze sialylation of a broad range of relevant acceptors was 
tested by performing transsialylation on HMO structures LNT, LNnT, LNFP V, LNnFP V as well as 
on a preparation of XOS and two different preparations of GOS (570-P and Cup Oligo P). As 
previously observed for Tr13, both Tr15 and Tr16 could also catalyze transsialylation of the two GOS 
preparations, which have a varying degree of polymerization (DP) range [17] (Table 4). 
Transsialylation of XOS has not previously been described, but both Tr15 and Tr16 catalyzed 
transsialylation of low-DP XOS using CGMP as sialyl donor (Table 4). The HMO core structure LNT 
was sialylated by both enzymes, whereas no sialylated LNnT could be detected by LC-MS (Table 4). 
This was surprising, since both HMOs have previously been sialylated by Tr6 [16]. Additionally, when 
an α(1,3)-linked fucosyl residue was present on the reducing end terminal glucose moiety (LNnFP V), 
detectable transsialylation did take place (Table 4). LNFP V was also sialylated by both Tr15 and Tr16 
(Table 4); this has also been reported previously for Tr6 [16]. In conclusion, the acceptor specificities 
of Tr15 and Tr16 are rather broad, making them useful for production of a wide range of α(2,3)-
sialylated HMO and HMO-like structures. Although the major sialylated HMO in human milk appears 
to be 6’SL (0.6 g/L corresponding to 7% (w/w) of total HMOs for secretors and 11% (w/w) for non-
secretors), appreciable levels of 3’SL (0.2–0.3 g/L) and LST a (terminally α(2,3)-sialylated LNT; 0.1-
0.3 g/L) have also been identified [2], emphasizing the importance of novel routes for production of 
these HMOs for future addition to infant formula.  
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Table 4. Transsialylation of a variety of HMO structures (LNT, LNnT, LNFP V, and LNnFP V), GOS, 
and xylooligosaccharides (XOS) by engineered sialidases Tr6, Tr13, Tr15, and Tr16. A plus (+) 
indicates that transsialylation takes place, a minus (−) that no transsialylation could be detected, while 
no sign indicates that the compound was not tested as acceptor.  
 Tr6a Tr13b Tr15 Tr16 
LNT +  + + 
LNnT +  − − 
LNFP V +  + + 
LNnFP V   + + 
XOS   + + 
GOS Cup Oligo P  + + + 
GOS 570-P  + + + 
aData from [16]; bdata from [17].  
 
3.5. Immobilization of Tr6 and Tr15 
 
As Tr15 was the most efficient of the engineered T. rangeli sialidases in terms of reaction rate and 
SL production (Figure 4; Table 3), Tr15 was selected for immobilization studies. Additionally, Tr6 was 
included as comparison since this engineered sialidase has previously been immobilized by a number 
of techniques, namely (i) His-tag immobilization on Cu2+-iminodiacetic acid-functionalized magnetic 
nanoparticles, (ii) immobilization by physical adsorption on a regenerated cellulose membrane, and 
(iii) calcium alginate encapsulation of glutaraldehyde cross-linked Tr6 [15]. However, cross-linking 
and encapsulation were harmful to enzyme activity and rendered the enzyme inactive, whereas 
membrane immobilization suffered from low enzyme loading [15]. Immobilization via the His-tag on 
the magnetic nanoparticles improved the biocatalytic productivity, but suffered from severe enzyme 
leakage and/or inactivation so that only 7% of the initial activity remained after seven consecutive 
reaction cycles [15].  
Two different methods of linking the enzyme covalently to the Sipernat 50S silica support were 
employed: (1) immobilization via glyoxyl groups promoted by alkaline conditions (pH 10.5), and (2) 
immobilization with glutaraldehyde to silica functionalized with APTES at neutral and acidic pH 
(Figure 5). To stabilize the enzyme at alkaline pH used in the glyoxyl method, galactose and glycerol 
were added to the immobilization mixture. In a preliminary study using 25% (v/v) glycerol and 100 
mM galactose during incubation at 4 °C for 2 hours (corresponding to the glyoxyl immobilization 
time), the remaining activity was tested on CGMP and lactose using an enzyme concentration of 300 
mg/L at the optimal pH of the enzyme. It was established that Tr6 and Tr15 retained 70–78% of their 
activity after incubation at alkaline conditions with glycerol and galactose: with Tr6 0.13 mM 3’SL 
was formed after incubation at pH 4.8 and 0.10 mM at pH 10.1 (corresponding to 78% remaining 
activity), whereas with Tr15 0.52 mM 3’SL was formed after incubation at pH 4.8 and 0.36 mM at pH 
10.1 (corresponding to 70% remaining activity). To avoid such enzyme inactivation, immobilization 
by the APTES-GA method was carried out at the optimal pH of the enzymes (pH 4.8–5.5) although 
the amino group reactivity is relatively low at acidic conditions.  
The immobilization efficiency was approximate 3% as determined from protein concentration of 
the immobilization mixture before and after immobilization (data not shown). In order to ensure 
successful immobilization of the engineered sialidases on the support, a large excess of enzyme was  
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Figure 5. Covalent immobilization methods employed: a) Glyoxyl method, where the engineered 
sialidase is immobilized on a glyoxyl-functionalized silica support [29]; b) APTES-GA method, 
where the engineered sialidase is immobilized on a silica support by functionalization with APTES 
and glutaraldehyde (GA); the assumed conformation of glutaraldehyde at neutral and acidic 
conditions is based on [25,32,37]. The N-terminal is shown in pink; its amino group has a lower 
pKa (7.7) than those of the Lys-side chains (10.5) [26] (shown in blue) and it is thus more likely to 
be uncharged at pH 4.8-5.5 and used for immobilization [23,29]. The active site is indicated by the 
bound 3’SL product (black).  
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offered to the support. As a consequence, the immobilization efficiency was low, but the amount of 
enzyme immobilized corresponded to an enzyme concentration of 17 mg/L in the 50 mL reaction, 
which was almost 3 times more than used in the previous reactions (Figure 4; Table 3). Even so, 
transsialylation yields were lower: a maximum 3’SL concentration of 145 µM 3’SL was achieved with 
17 mg/L free Tr15 after 1 hour of reaction, which is less than one third of what was achieved with 6 
mg/L free Tr15 in 1 hour (453 µM 3’SL). Probably, the increase in enzyme dosage and corresponding 
acceleration of primary and secondary hydrolysis caused a shift in the transient maximum to a shorter 
reaction time. It has previously been observed that high enzyme dosages are detrimental to 
transglycosylation yields [51].  
In addition, regioselectivity was affected by the increased enzyme concentration. For free Tr6 (17 
mg/L), regioselectivity towards formation of 3’SL decreased over the 6 hours, starting at 95% after 1 
hour and decreasing to 71% after 6 hours, whereas it decreased from 90 to 82% for free Tr15. For 
comparison, regioselectivity was 97% for free Tr15 at 6 mg/L (Table 3). The regioselectivity was 
improved by immobilization: the regioselectivity towards 3’SL was complete for APTES-GA-TrX and 
at least 92% for the glyoxyl-Tr15 and at least 93% for glyoxyl-Tr6. In all cases, the main byproduct 
was 3SL. It has previously been observed, that regioselectivity of sialidases was compromised by 
immobilization [52,53]. However, in this case, it is evident that both enzyme dosage and 
immobilization affect regioselectivity.  
Comparing the immobilized sialidases to their free counterparts, the remaining activity was 
around 50% for the glyoxyl method and around 10% for the APTES-GA method when considering the 
amount of 3’SL produced during the first hour of reaction. Covalent immobilization has often been 
found to compromise enzyme activity as it may disturb the three-dimensional structure [34,38]. Such 
a decrease is however often compensated by a higher enzyme stability [23]. Comparing the two 
covalent immobilization methods, it is evident that much higher transsialylation yields were obtained 
with the glyoxyl method (Figure 6). While 20–25% of the activity of TrX was lost during incubation 
at high pH in the glyoxyl method, this method still provided a more active enzyme than the APTES-
GA method. Remaining activities between 7% and 40% compared to the free enzyme are commonly 
reported for the APTES-GA method [38,54,55]. When operated at acidic or neutral pH this method is 
expected to create initial unipoint immobilization by formation of a linkage to the N-terminal amine. 
In the case of TrX, the distance from the N-terminal to the active site is only approximate 26 Å and 
they are on the same face of the enzyme. Thus, it is conceivable that the active site is partially blocked 
upon APTES-GA immobilization. In contrast, the glyoxyl method which targets the amine groups of 
lysine, makes it possible for the immobilized enzyme to adopt more orientations, making it more likely 
that the active site will often face the solution.  
Two different methods were employed for recycling the enzyme: (1) centrifugation, where the 
immobilized enzyme was removed from the reaction mixture after each 50-minute cycle and added to 
a new bacth or reaction mixture, or (2) fed-batch, where additional new substrate was simple added to 
the reaction vessel after each 50-minute reaction cycle. Obviously, the fed-batch operation could also 
be carried out with free enzyme, but the use of immobilized enzyme allows for subsequent recovery 
and use in a new fed-batch operation. The fed-batch results indicate that the immobilized sialidases 
were stable in the reaction mixture for at least 6 hours (Supplementary Figure S1). The difference in 
transsialylation yield was not significant between the two recycling methods (Figure 7), but it is 
evident that some activity was lost in the centrifugation method, where the biocatalyst was separated 
from the reaction mixture after each cycle: for the glyoxyl method, the 3’SL concentration obtained in 
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the sixth cycle was around 70% of that obtained in the first cycle, whereas it was only around 50% for 
the APTES method (Figure 6). This could either be due to leakage of the enzyme from the support or 
because not all of the biocatalyst is recovered in the pellet after centrifugation. In case of the former, 
the glyoxyl method appears to provide a stronger linkage between the enzyme and the support, as less 
enzyme activity is lost. This may be due to the multipoint attachment facilitated by the glyoxyl method 
(Figure 5) [23,29].  
 
 
 
Figure 6. Recycling of immobilized Tr6 and Tr15 by centrifugation. Concentration of 3’SL 
obtained after immobilization of Tr6 and Tr15 on silica support by glyoxyl or APTES-GA 
linking. The immobilized sialidases were recycled in 6 consecutive 50-minute reaction cycles 
by removal of the biocatalyst from the reaction mixture by centrifugation. Reactions took place 
at optimal pH and 30 °C using 8 mM sialic acid bound in CGMP as sialyl donor and 80 mM 
lactose as acceptor. Standard deviations of duplicate experiments are indicated. Lowercase 
letters indicate significant difference between values (p < 0.05).  
 
In terms of biocatalytic productivity (amount of product per amount of enzyme), a 1.5-fold 
increase was obtained for 6 cycles with the glyoxyl method compared to the free enzyme (Figure 7). 
Although the immobilization was fairly stable, the initial activity of the immobilized enzyme appeared 
decreased, giving rise to fairly low transsialylation yields and hence a lower increase in biocatalytic 
productivity after immobilization than expected. However, as the enzymes appeared to maintain their 
activity for extended reaction times in the fed-batch recycling (Figure S1), it is likely that a larger 
improvement in biocatalytic productivity could be obtained if the enzyme was recycled more than six 
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times using the glyoxyl immobilization method. For the APTES-GA method, the biocatalytic 
productivity was less than half of that obtained with the free enzyme, and this method is thus not 
recommendable for the current system (Figure 7). Previously, it was found that immobilization of Tr6 
via the His-tag on Cu2+-iminodiacetic acid-functionalized magnetic nano-particles increased the 
biocatalytic productivity 2.5 times. This method however suffered from severe enzyme leakage, to 
a much higher extent than observed for the covalent immobilization methods employed here (Figure 
6) [15]. Instead, it was shown that using free Tr6 or Tr13 in a membrane reactor was an efficient way 
of recycling the engineered sialidases in the transsialylation process, since the biocatalytic productivity 
was increased 7 to 9 times compared to the batch reaction [15,17]. Possibly, the use of a bulky sialyl 
donor (CGMP) favors the use of free enzyme in these reactions. The engineered TrSA variants are 
structurally similar to the β-galactosidase from Aspergillus aculeatus, which was previously 
immobilized in the glyoxyl-functionalized silica support giving rise to improved transglycosylation 
yields [35], as they are monomeric and have a similar average diameter. Thus, immobilization of Tr6 
and Tr15 in the silica support should not be hampered by mass transfer issues. However, CGMP has a 
pH-dependent apparent molecular mass which varies from 10–30 kDa at pH 3.5 to 20–50 kDa at pH 
7.0, even though the theoretical molecular mass is only 7–10 kDa [56]. Thus, the lower transsialylation 
activity observed upon immobilization of Tr6 and Tr15 in the current study may be caused by mass 
transfer limitations for the sialyl donor.   
Finally, the results obtained with the glyoxyl-immobilized sialidases corroborate that Tr15 
transsialylation was improved compared to its predecessor Tr6 (Figures 6 and 7). For the APTES-GA 
method, the yields were too low to reveal any possible differences in performance between the two 
engineered sialidases (Figures 6 and 7).   
 
 
 
Figure 7. Biocatalytic productivity of immobilized and free Tr6 and Tr15. Given as mg 3’SL 
produced per mg enzyme. Standard deviations of duplicate experiments are indicated. 
Lowercase letters indicate significant difference between the values (p < 0.05).  
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4. Conclusions 
 
When aiming to catalyze transglycosylation with a glycosidase, a number of parameters influence 
the transglycosylation performance, including transsialylation and hydrolysis rates, pH optimum, 
acceptor-to-donor ratio, and acceptor specificity. Of the two superior variants of the engineered 
sialidase from T. rangeli, Tr15 stood out as the most efficient enzyme for transsialylation due to higher 
reaction rates, although Tr16 exhibited a higher ratio between the transsialylation rate and the 
hydrolysis rate. Both enzymes showed broad acceptor specificity and are thus good candidates for 
enzymatic production of α(2,3)-sialylated glycans including HMOs. Immobilization of Tr6 and Tr15 
on glyoxyl-functionalized silica led to an increase in biocatalytic productivity, even though ultrafiltered 
cell-free extracts were used in the immobilization process without extra enzyme purification. 
Furthermore, the use of glyoxyl-functionalized silica proved to be markedly better for immobilization 
than silica functionalized with APTES and glutaraldehyde. However, combining these results with 
previously obtained results on immobilization of Tr6, it is evident that immobilization of the 
engineered sialidases may introduce mass transfer limitations due to the use of a bulky sialyl donor 
(CGMP), resulting in reduced transsialylation activity.  
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